论文信息 - Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study - 字舞流文

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

H. Dombret | C. Gardin | C. Récher | O. Reman | P. Rousselot | C. Chomienne | O. Maarek | E. Raffoux | L. Degos | J. Marolleau | J. Malfuson | S. Maury | P. Turlure | A. Cras | A. Labarthe